Bruker–Cowen: investor conference, 201803 supply service Bruker presents at Cowen & Co Annual Health Care Conference 2018

	Period	2018-03-12
	Region	Boston, MA
	Country	United States (USA)
	Predecessor	Bruker–Cowen: investor conference, 201703 supply service Bruker presents at Cowen & Co Annual Health Care Conference 2017
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Partner, 2nd	Cowen & Company LLC
	Group	TD Bank (Group)
	Product	Cowen & Co. Annual Health Care Conference 2018 Boston
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (3/6/18). "Press Release: Bruker Corporation to Present at Cowen’s 38th Annual Health Care Conference". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will participate in Cowen's 38th Annual Health Care Conference in Boston. Frank Laukien, President and CEO, will present on behalf of the company on Monday, March 12th, 2018 at 1:30 PM Eastern Time.

A live audio webcast of the presentation will be available on the Investors section of the Company's website at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com.

Contact :

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com